The Cognitive Neuroscience of Psychological Treatment Action in Depression and Anxiety

Current Behavioral Neuroscience Reports

Volumn 5, Issue 1, 2018, Pages 13-25

  Young, Katherine S ^a   Craske, Michelle G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Cognitive behavioral therapy; Depression; Mechanisms; MRI; Treatment

Indexed keywords

EID: 85052526732     PISSN: None     EISSN: 21962979     Source Type: Journal    
DOI: 10.1007/s40473-018-0137-x     Document Type: Review

References (56)

1. Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21(3):169–84. 10.1002/mpr.1359. DOI: 10.1002/mpr.1359
2. Loerinc AG, Meuret AE, Twohig MP, Rosenfield D, Bluett EJ, Craske MG. Response rates for CBT for anxiety disorders: need for standardized criteria. Clin Psychol Rev. 2015;42:72–82. 10.1016/j.cpr.2015.08.004. DOI: 10.1016/j.cpr.2015.08.004
3. Cuijpers P, Karyotaki E, Weitz E, Andersson G, Hollon SD, van Straten A. The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. J Affect Disord. 2014;159:118–26. 10.1016/j.jad.2014.02.026. DOI: 10.1016/j.jad.2014.02.026
4. Craske MG. Introduction to special issue: how does neuroscience inform psychological treatment? Behav Res Ther. 2014;62:1–2. 10.1016/j.brat.2014.08.014. DOI: 10.1016/j.brat.2014.08.014
5. Holmes EA, Craske MG, Graybiel AM. A call for mental-health science. Nature. 2014;511(7509):287–9. 10.1038/511287a. DOI: 10.1038/511287a
6. Fredrikson M, Faria V. Neuroimaging in anxiety disorders. Anxiety disorders Karger Publishers. 2013:47–66. 10.1159/000351938.
7. Kim MJ, Loucks RA, Palmer AL, Brown AC, Solomon KM, Marchante AN, et al. The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety. Behav Brain Res. 2011;223(2):403–10. 10.1016/j.bbr.2011.04.025.
8. Pandya M, Altinay M, Malone DA, Anand A. Where in the brain is depression? Current Psychiatry Reports. 2012;14(6):634–42. 10.1007/s11920-012-0322-7. DOI: 10.1007/s11920-012-0322-7
9. Mathews A, MacLeod C. Cognitive vulnerability to emotional disorders. Annu Rev Clin Psychol. 2005;1(1):167–95. 10.1146/annurev.clinpsy.1.102803.143916. DOI: 10.1146/annurev.clinpsy.1.102803.143916
10. Thomsen KR, Whybrow PC, Kringelbach ML. Reconceptualizing anhedonia: novel perspectives on balancing the pleasure networks in the human brain. Front Behav Neurosci. 2015;9
11. Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. The Canadian J Psychiatry. 2013;58(7):376–85. 10.1177/070674371305800702. DOI: 10.1177/070674371305800702
12. Craske MG. Cognitive behavior therapy. Second ed. Washington, DC: American Psychological Association; 2017.
13. Cuijpers P, Van Straten A, Warmerdam L. Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev. 2007;27(3):318–26. 10.1016/j.cpr.2006.11.001.
14. Cristea IA, Kok RN, Cuijpers P. Efficacy of cognitive bias modification interventions in anxiety and depression: meta-analysis. Br J Psychiatry. 2015;206(1):7–16. 10.1192/bjp.bp.114.146761. DOI: 10.1192/bjp.bp.114.146761
15. Ludwig DS, Kabat-Zinn J. Mindfulness in medicine. JAMA. 2008;300(11):1350–2. DOI: 10.1001/jama.300.11.1350
16. Kazdin AE. Mediators and mechanisms of change in psychotherapy research. Annu Rev Clin Psychol. 2007;3:1–27. DOI: 10.1146/annurev.clinpsy.3.022806.091432
17. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59(10):877–83. 10.1001/archpsyc.59.10.877. DOI: 10.1001/archpsyc.59.10.877
18. Yoshimura S, Okamoto Y, Matsunaga M, Onoda K, Okada G, Kunisato Y, et al. Cognitive behavioral therapy changes functional connectivity between medial prefrontal and anterior cingulate cortices. J Affect Disord. 2017;208:610–4. 10.1016/j.jad.2016.10.017.
19. Sankar A, Scott J, Paszkiewicz A, Giampietro V, Steiner H, Fu C. Neural effects of cognitive–behavioural therapy on dysfunctional attitudes in depression. Psychol Med. 2015;45(7):1425–33. 10.1017/S0033291714002529.
20. Straub J, Plener P, Sproeber N, Sprenger L, Koelch M, Groen G, et al. Neural correlates of successful psychotherapy of depression in adolescents. J Affect Disord. 2015;183:239–46. 10.1016/j.jad.2015.05.020. DOI: 10.1016/j.jad.2015.05.020
21. Chuang J-Y, Whitaker KJ, Murray GK, Elliott R, Hagan CC, Graham JM, et al. Aberrant brain responses to emotionally valent words is normalised after cognitive behavioural therapy in female depressed adolescents. J Affect Disord. 2016;189:54–61. 10.1016/j.jad.2015.09.008. DOI: 10.1016/j.jad.2015.09.008
22. Goldin PR, Ziv M, Jazaieri H, Hahn K, Heimberg R, Gross JJ. Impact of cognitive behavioral therapy for social anxiety disorder on the neural dynamics of cognitive reappraisal of negative self-beliefs: randomized clinical trial. JAMA psychiatry. 2013;70(10):1048–56. 10.1001/jamapsychiatry.2013.234. DOI: 10.1001/jamapsychiatry.2013.234
23. • Goldin PR, Ziv M, Jazaieri H, Weeks J, Heimberg RG, Gross JJ. Impact of cognitive-behavioral therapy for social anxiety disorder on the neural bases of emotional reactivity to and regulation of social evaluation. Behav Res Ther. 2014;62:97–106. Example of investigation of treatment-relevant mechanisms in a neuroimaging study of CBT for social anxiety disorder. DOI: 10.1016/j.brat.2014.08.005
24. Månsson KN, Carlbring P, Frick A, Engman J, Olsson C-J, Bodlund O, et al. Altered neural correlates of affective processing after internet-delivered cognitive behavior therapy for social anxiety disorder. Psychiatry Res Neuroimaging. 2013;214(3):229–37. 10.1016/j.pscychresns.2013.08.012. DOI: 10.1016/j.pscychresns.2013.08.012
25. Fonzo GA, Ramsawh HJ, Flagan TM, Sullivan SG, Simmons AN, Paulus MP, et al. Cognitive-behavioral therapy for generalized anxiety disorder is associated with attenuation of limbic activation to threat-related facial emotions. J Affect Disord. 2014;169:76–85. 10.1016/j.jad.2014.07.031.
26. Kircher T, Arolt V, Jansen A, Pyka M, Reinhardt I, Kellermann T, et al. Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder. Biol Psychiatry. 2013;73(1):93–101. 10.1016/j.biopsych.2012.07.026.
27. Lueken U, Straube B, Konrad C, Wittchen H-U, Ströhle A, Wittmann A, et al. Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia. Am J Psychiatr. 2013;170(11):1345–55. 10.1176/appi.ajp.2013.12111484.
28. Liebscher C, Wittmann A, Gechter J, Schlagenhauf F, Lueken U, Plag J, et al. Facing the fear–clinical and neural effects of cognitive behavioural and pharmacotherapy in panic disorder with agoraphobia. Eur Neuropsychopharmacol. 2016;26(3):431–44. 10.1016/j.euroneuro.2016.01.004.
29. Lipka J, Hoffmann M, Miltner WH, Straube T. Effects of cognitive-behavioral therapy on brain responses to subliminal and supraliminal threat and their functional significance in specific phobia. Biol Psychiatry. 2014;76(11):869–77. 10.1016/j.biopsych.2013.11.008. DOI: 10.1016/j.biopsych.2013.11.008
30. Soravia LM, Orosz A, Schwab S, Nakataki M, Wiest R, Federspiel A. CBT reduces CBF: cognitive-behavioral therapy reduces cerebral blood flow in fear-relevant brain regions in spider phobia. Brain and behavior. 2016;6(9):e00510. 10.1002/brb3.510. DOI: 10.1002/brb3.510
31. Shiota S, Okamoto Y, Okada G, Takagaki K, Takamura M, Mori A, et al. Effects of behavioural activation on the neural basis of other perspective self-referential processing in subthreshold depression: a functional magnetic resonance imaging study. Psychol Med. 2017;47(5):877–88. 10.1017/S0033291716002956.
32. Mori A, Okamoto Y, Okada G, Takagaki K, Jinnin R, Takamura M, et al. Behavioral activation can normalize neural hypoactivation in subthreshold depression during a monetary incentive delay task. J Affect Disord. 2016;189:254–62. 10.1016/j.jad.2015.09.036.
33. Goldin P, Ziv M, Jazaieri H, Hahn K, Gross JJ. MBSR vs aerobic exercise in social anxiety: fMRI of emotion regulation of negative self-beliefs. Soc Cogn Affect Neurosci. 2012;8(1):65–72. 10.1093/scan/nss054. DOI: 10.1093/scan/nss054
34. Britton JC, Suway JG, Clementi MA, Fox NA, Pine DS, Bar-Haim Y. Neural changes with attention bias modification for anxiety: a randomized trial. Soc Cogn Affect Neurosci. 2014;10(7):913–20. 10.1093/scan/nsu141. DOI: 10.1093/scan/nsu141
35. Shou H, Yang Z, Satterthwaite TD, Cook PA, Bruce SE, Shinohara RT, et al. Cognitive behavioral therapy increases amygdala connectivity with the cognitive control network in both MDD and PTSD. NeuroImage: Clinical. 2017;14:464–70. 10.1016/j.nicl.2017.01.030.
36. Chattopadhyay S, Tait R, Simas T, van Nieuwenhuizen A, Hagan CC, Holt RJ, et al. Cognitive behavioral therapy lowers elevated functional connectivity in depressed adolescents. EBioMedicine. 2017;17:216–22. 10.1016/j.ebiom.2017.02.010.
37. Straub J, Metzger C, Plener P, Koelch M, Groen G, Abler B. Successful group psychotherapy of depression in adolescents alters fronto-limbic resting-state connectivity. J Affect Disord. 2017;209:135–9. 10.1016/j.jad.2016.11.024. DOI: 10.1016/j.jad.2016.11.024
38. Jacobs RH, Watkins ER, Peters AT, Feldhaus CG, Barba A, Carbray J, et al. Targeting ruminative thinking in adolescents at risk for depressive relapse: rumination-focused cognitive behavior therapy in a pilot randomized controlled trial with resting state fMRI. PLoS One. 2016;11(11):e0163952. 10.1371/journal.pone.0163952.
39. Yuan M, Zhu H, Qiu C, Meng Y, Zhang Y, Shang J, et al. Group cognitive behavioral therapy modulates the resting-state functional connectivity of amygdala-related network in patients with generalized social anxiety disorder. BMC psychiatry. 2016;16(1):198. 10.1186/s12888-016-0904-8. DOI: 10.1186/s12888-016-0904-8
40. Young KS, Burklund LJ, Torre JB, Saxbe D, Lieberman MD, Craske MG. Treatment for social anxiety disorder alters functional connectivity in emotion regulation neural circuitry. Psychiatry Res Neuroimaging. 2017;261:44–51. 10.1016/j.pscychresns.2017.01.005. DOI: 10.1016/j.pscychresns.2017.01.005
41. Månsson KN, Salami A, Carlbring P, Boraxbekk C-J, Andersson G, Furmark T. Structural but not functional neuroplasticity one year after effective cognitive behaviour therapy for social anxiety disorder. Behav Brain Res. 2017;318:45–51. 10.1016/j.bbr.2016.11.018. DOI: 10.1016/j.bbr.2016.11.018
42. • Månsson KN, Salami A, Frick A, Carlbring P, Andersson G, Furmark T, et al. Neuroplasticity in response to cognitive behavior therapy for social anxiety disorder. Translational Psychiatry. 2016;6(2):–e727. Example of a study using mediation analysis to investigate changes in neural function and structure in relation to treatment outcomes.
43. Steiger V, Brühl A, Weidt S, Delsignore A, Rufer M, Jäncke L, et al. Pattern of structural brain changes in social anxiety disorder after cognitive behavioral group therapy: a longitudinal multimodal MRI study. Mol Psychiatry. 2016;
44. Yoshimura S, Okamoto Y, Onoda K, Matsunaga M, Okada G, Kunisato Y, et al. Cognitive behavioral therapy for depression changes medial prefrontal and ventral anterior cingulate cortex activity associated with self-referential processing. Soc Cogn Affect Neurosci. 2013;9(4):487–93. 10.1093/scan/nst009.
45. Cunningham WA, Brosch T. Motivational salience: amygdala tuning from traits, needs, values, and goals. Curr Dir Psychol Sci. 2012;21(1):54–9. 10.1177/0963721411430832. DOI: 10.1177/0963721411430832
46. Uddin LQ. Salience processing and insular cortical function and dysfunction. Nature Rev Neurosci. 2014;16(1):nrn3857.
47. Ochsner KN, Silvers JA, Buhle JT. Functional imaging studies of emotion regulation: a synthetic review and evolving model of the cognitive control of emotion. Ann N Y Acad Sci. 2012;1251(1):E1–E24. 10.1111/j.1749-6632.2012.06751.x. DOI: 10.1111/j.1749-6632.2012.06751.x
48. Amodio DM, Frith CD. Meeting of minds: the medial frontal cortex and social cognition. Nat Rev Neurosci. 2006;7(4):268–77. 10.1038/nrn1884. DOI: 10.1038/nrn1884
49. Paulus MP, Stein MB. An insular view of anxiety. Biol Psychiatry. 2006;60(4):383–7. 10.1016/j.biopsych.2006.03.042. DOI: 10.1016/j.biopsych.2006.03.042
50. Taylor CT, Aupperle RL, Flagan T, Simmons AN, Amir N, Stein MB, et al. Neural correlates of a computerized attention modification program in anxious subjects. Soc Cogn Affect Neurosci. 2013;9(9):1379–87. 10.1093/scan/nst128.
51. Fox E, Zougkou K, Ashwin C, Cahill S. Investigating the efficacy of attention bias modification in reducing high spider fear: the role of individual differences in initial bias. J Behav Ther Exp Psychiatry. 2015;49(Pt A):84–93. 10.1016/j.jbtep.2015.05.001. DOI: 10.1016/j.jbtep.2015.05.001
52. Godlewska B, Browning M, Norbury R, Cowen PJ, Harmer CJ. Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression. Transl Psychiatry. 2016;6(11):e957. 10.1038/tp.2016.130. DOI: 10.1038/tp.2016.130
53. •• Craske MG, Meuret AE, Ritz T, Treanor M, Dour HJ. Treatment for anhedonia: a neuroscience driven approach. Depression Anxiety. 2016;33(10):927–38. Example of neuroscience-informed clinical research – utilizing knowledge from the neuroscientific investigation of depression as a deficit in positive valence (reward) systems to develop a novel transdiagnostic psychological therapy. DOI: 10.1002/da.22490
54. Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 2013;11(1):1.
55. Poldrack RA, Baker CI, Durnez J, Gorgolewski KJ, Matthews PM, Munafò MR, et al. Scanning the horizon: towards transparent and reproducible neuroimaging research. Nat Rev Neurosci. 2017;18(2):115–26. 10.1038/nrn.2016.167.
56. Yarkoni T, Vul, et al. Big correlations in little studies: inflated fMRI correlations reflect low statistical power—commentary on. Perspect Psychol Sci 2009. 2009;4(3):294–8. DOI: 10.1111/j.1745-6924.2009.01127.x